Acumen Pharmaceuticals, Inc. (ABOS) vs Minerva Neurosciences, Inc (NERV)
Acumen Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Minerva Neurosciences, Inc are of similar size ($164.7M and $161.6M). Across the 8 metrics below, Acumen Pharmaceuticals, Inc. leads on 4 and Minerva Neurosciences, Inc on 4.
Valuation
Profitability
| Metric | ABOS | NERV | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (120.50%) | 322.05% | (57.72%) |
| Return on assets | (72.97%) | (629.71%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack